ReviewRNA (New York, N.Y.)2026
Machine learning for RNA secondary structure prediction: a review of current methods and challenges.
Review in RNA (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Unraveling the Mechanism of Drug Binding to SARS-CoV-2 RNA Pseudoknot With Thermodynamics-Driven Machine Learning.Journal of computational chemistry · 2026Article
- Exploring Secondary Structure Predictions for RNA-Targeted Drug Discovery: Power and Challenges.Journal of chemical information and modeling · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting the secondary structure of RNA is a core challenge in computational biology, essential for understanding molecular function and designing novel therapeutics. The field has evolved from foundational but accuracy-limited thermodynamic approaches to a new data-driven paradigm dominated by machine learning and deep learning. These models learn folding patterns directly from data, leading to significant performance gains. This review surveys the modern landscape of these methods, covering single-sequence, evolutionary-based, and hybrid models that blend machine learning with biophysics. A central theme is the field's "generalization crisis," where powerful models were found to fail on new RNA families, prompting a community-wide shift to stricter, homology-aware benchmarking. In response to the underlying challenge of data scarcity, RNA foundation models have emerged, learning from massive, unlabeled sequence corpora to improve generalization. Finally, we look ahead to the next set of major hurdles-including the accurate prediction of complex motifs like pseudoknots, scaling to kilobase-length transcripts, incorporating the chemical diversity of modified nucleotides, and shifting the prediction target from static structures to the dynamic ensembles that better capture biological function. We also highlight the need for a standardized, prospective benchmarking system to ensure unbiased validation and accelerate progress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.